ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
NYSE:ADCT
Price:
4.72 USD
-0.84%
Market Closed
Updated:
Apr 20, 2024
ADC Therapeutics SA
Depreciation & Amortization
Last
Value
3-Years CAGR
5-Years CAGR
|
ADC Therapeutics SA
Depreciation & Amortization Peer Comparison
Comparables:
ACIU
CRSP
BSLN
IDIA
KURN
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Depreciation & Amortization
$2.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Depreciation & Amortization
CHf2.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Depreciation & Amortization
$19.8m
|
CAGR 3-Years
29%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Depreciation & Amortization
CHf1.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Idorsia Ltd
SIX:IDIA
|
Depreciation & Amortization
CHf19.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Depreciation & Amortization
CHf2.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Depreciation & Amortization?
Depreciation & Amortization
2.3m
USD
2.3m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Depreciation & Amortization amounts to 2.3m USD.
What is ADC Therapeutics SA's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
37%
37%
Over the last year, the Depreciation & Amortization growth was 0%. The average annual Depreciation & Amortization growth rates for ADC Therapeutics SA have been 3% over the past three years , 37% over the past five years .
You don't have any saved screeners yet
